GAMOGEN INC
10QSB, EX-27, 2000-06-19
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: GAMOGEN INC, 10QSB, 2000-06-19
Next: NORWEST ADVANTAGE FUNDS /ME/, 40-8F-M, 2000-06-19



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          FEB-28-2000
<PERIOD-END>                               MAY-31-2000
<CASH>                                          26,661
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                26,661
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 216,708
<CURRENT-LIABILITIES>                           10,400
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        27,500
<OTHER-SE>                                     178,808
<TOTAL-LIABILITY-AND-EQUITY>                   216,708
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                   269
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  2,714
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              2,714
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,714
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission